General Information of Drug (ID: DMASKX9)

Drug Name
PF-06342674 Drug Info
Indication
Disease Entry ICD 11 Status REF
Type-1 diabetes 5A10 Phase 1 [1]
Type-2 diabetes 5A11 Phase 1 [2]
Cross-matching ID
TTD Drug ID
DMASKX9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CYT 99007 DMMWIHC Acquired immune deficiency syndrome 1C62.3 Phase 2 [4]
ADX-914 DMYM6FU Atopic dermatitis EA80 Phase 2 [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 7 receptor alpha (IL7R) TTAWI51 IL7RA_HUMAN Antagonist [3]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037233)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Perspectives on interleukin-7 therapy in HIV infection. Curr Opin HIV AIDS. 2007 May;2(3):228-33.
5 Clinical pipeline report, company report or official report of Q32bio